Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/33376
Share/Export:
![]() ![]() |
|
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Title: | Glutamate-based antidepressants: 20 years on |
Authors: | Skolnick, Phil; Popik, Piotr; Trullas, Ramón CSIC ORCID | Issue Date: | Nov-2009 | Publisher: | Elsevier | Citation: | Trends in Pharmacological Sciences 30(11): 563-569 (2009) | Abstract: | Depression is a chronic recurring illness that affects more than 120 million people worldwide. Drugs increasing the synaptic availability of serotonin and norepinephrine (biogenic amine-based agents) have been used to treat depression for more than 50 years. However, significant symptom improvement requires ≥2–4 weeks of treatment and a first course of therapy provides symptom relief to only 60–65% of patients. Roche and Evotec recently announced plans to develop N-methyl-D-aspartate (NMDA) receptor antagonists targeting the NR2B subtype for treatment-resistant depression. This announcement closely follows a report that another NR2B antagonist, traxoprodil (CP 101 606), has antidepressant effects in patients unresponsive to a serotonin selective reuptake inhibitor, as well as reports of rapid and sustained antidepressant effects following a single injection of the NMDA antagonist ketamine. Here we describe evidence that glutamate-based therapies might represent an effective alternative to biogenic-amine-based agents for depression and provide perspectives on the development of these agents. | Description: | El pdf del artículo es el manuscrito de autor. | Publisher version (URL): | http://dx.doi.org/10.1016/j.tips.2009.09.002 | URI: | http://hdl.handle.net/10261/33376 | DOI: | 10.1016/j.tips.2009.09.002 | ISSN: | 0165-6147 | E-ISSN: | 1873-3735 |
Appears in Collections: | (IIBB) Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Glutamate-based.pdf | 588,96 kB | Adobe PDF | ![]() View/Open |
Review this work
SCOPUSTM
Citations
329
checked on May 21, 2022
WEB OF SCIENCETM
Citations
301
checked on May 18, 2022
Page view(s)
361
checked on May 22, 2022
Download(s)
607
checked on May 22, 2022
Google ScholarTM
Check
Altmetric
Dimensions
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.